In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of ...

Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.

Sartorius Stedim Biotech reported preliminary fiscal 2024 net profit of 175.1 million euros, down 43.6% from last year. Earnings per ...

Sartorius (SARTF) jumps as the company projects a positive outlook with its 2024 results sending its U.S. peers, Repligen ...

French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for bioprocessing innovation in Marlborough, Massachusetts, US. The centre encourages teamwork ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Sartorius (0NIR – Research Report) today and set a price target of €230.00. The ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has launched the single- use ultrafilter Sartocon® Slice 50. The new crossflow filter device is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell ...